U.S. markets closed

NGM Biopharmaceuticals, Inc. (NGM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.22-0.23 (-1.18%)
At close: 4:00PM EDT
19.22 0.00 (0.00%)
After hours: 04:41PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close19.45
Open19.40
Bid18.76 x 900
Ask19.22 x 800
Day's Range18.52 - 19.40
52 Week Range14.90 - 32.12
Volume278,401
Avg. Volume365,612
Market Cap1.48B
Beta (5Y Monthly)1.99
PE Ratio (TTM)N/A
EPS (TTM)-1.57
Earnings DateAug 10, 2021 - Aug 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • NGM Bio to Present at Two Upcoming Investor Conferences
    GlobeNewswire

    NGM Bio to Present at Two Upcoming Investor Conferences

    SOUTH SAN FRANCISCO, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, will present an overview of the company and provide a business update at two upcoming investor conferences. Wednesday, June 9, 2021Event: Goldman Sachs 42nd Annual Global Healthcare ConferenceTime: 4:40 pm ET M

  • NGM Biopharmaceuticals (NGM) Stock Jumps 7%: Will It Continue to Soar?
    Zacks

    NGM Biopharmaceuticals (NGM) Stock Jumps 7%: Will It Continue to Soar?

    NGM Biopharmaceuticals (NGM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

  • ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NGM Biopharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
    Newsfile

    ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NGM Biopharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

    Los Angeles, California--(Newsfile Corp. - June 2, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of NGM Biopharmaceuticals, Inc. ("NGM" or "the Company") (NASDAQ: NGM) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. NGM announced on May 24, 2021, that it would b